Page 82 - FINAL PROGRAMME 2017

MONDAY, 3 JULY 2017
SELECTED ORAL COMMUNICATIONS
15:15 - 16:30 Room C
Session 21: Reproduction after cancer treatment
Chairman: K.L.T. Macklon (Denmark) Chairman: A. Chanson (Switzerland)
15:15
O-081 Long-term effect of childhood cancer treatment on ovarian function markers: nal results of the DCOG-LATER VEVO study
A. Overbeek1, M. Van Den Berg2, C. Lambalk1, G. Kaspers2,3, D. Bresters4,
M. Van Den Heuvel-Eibrink5, L. Kremer6, J. Loonen7, W. Tissing8, B. Versluys9, M. Hauptmann10, J. Twisk11,12, F. Van Leeuwen10, E. Van Dulmen-den Broeder2
1VU University Medical Center, Obstetrics and Gynaecology, Amsterdam, The Netherlands
2VU University Medical Center, Paediatrics, Amsterdam, The Netherlands
3Princess Máxima Center for Pediatric Oncology, Pediatric Oncology, Utrecht, The Netherlands
4Willem-Alexander Children’s Hospital/Leiden University Medical Center, Pediatric Oncology, Leiden, The Netherlands
5Sophia Children’s Hospital/Erasmus MC University Medical Center, Paediatric oncology, Rotterdam, The Netherlands
6Emma Children’s Hospital/Academic Medical Center, Paediatric Oncology, Amsterdam, The Netherlands
7Radboud University Medical Center, Paediatric Oncology, Nijmegen, The Netherlands 8University Medical Center Groningen, Paediatric Oncology, Groningen, The Netherlands 9Wilhelmina’s Children’s Hospital, Paediatric Oncology, Utrecht, The Netherlands 10Netherlands Cancer Institute, Epidemiology and Biostatistics, Amsterdam, The Netherlands 11VU University Medical Center, Epidemiology and Biostatistics, Amsterdam, The Netherlands
12VU University Medical Center, EMGO+ Institute for Health and Care Research, Amsterdam, The Netherlands
82